Ortho Clinical Diagnostics Holdings plc

NASDAQ:OCDX   3:06:38 PM EDT
17.41
-0.50 (-2.79%)
Other Pre-Announcement

Ortho Clinical Diagnostics Announces Preliminary Financial Results For Fourth Quarter And Fiscal Year 2021

Published: 01/06/2022 22:21 GMT
Ortho Clinical Diagnostics Holdings plc (OCDX) - Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021.
Q4 Core Revenue Excluding Cov-2 Assay Sales Expected to Increase About 7% to a Range of $508 Million to $510 Million.
Q4 Total Revenue is Expected to Increase Approximately 1% to a Range of $520 Million to $522 Million.
Q4 Revenue View $521.2 Million -- Refinitiv Ibes Data (analyst estimates).
Q4 Revenue View $521.2 Million -- Refinitiv Ibes Data (analyst estimates).
FY2021 Revenue View $2.04 Billion -- Refinitiv Ibes Data (analyst estimates).